Paper39003018
Vaccine value profile for herpes simplex virus.
Johnston C and 12 others. Vaccine, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Vaccine value profile for herpes simplex virus. Papers, record 39003018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39003018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Herpesvirus 2, Human | Major topic |
| Herpes Simplex Virus Vaccines | Major topic |
| Herpes Genitalis | Major topic |
| Herpes Simplex | Major topic |
| Humans | |
| Herpesvirus 1, Human | |
| Vaccination |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed | |
| MR/X020258/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42499178 | A Decade of the Global STI Vaccine Roadmap: Progress, Gaps and Challenges. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42499178 | PubMed |
| 42234759 | Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis. | Sci Adv | 2026 | https://conductscience.org/library/papers/42234759 | PubMed |
| 42185525 | Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42185525 | PubMed |
| 41627575 | Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions. | Curr HIV/AIDS Rep | 2026 | https://conductscience.org/library/papers/41627575 | PubMed |
| 40825575 | Extracellular Vesicles Containing MDP Derived from Lactobacillus rhamnosus GG Inhibit HSV-2 Infection by Activating the NOD2-IFN-I Signalling Pathway. | J Extracell Vesicles | 2025 | https://conductscience.org/library/papers/40825575 | PubMed |
| 40630608 | Beyond behavioural change: prioritising structural solutions to control bacterial sexually transmitted infections. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/40630608 | PubMed |
| 40574945 | Neonatal herpes simplex virus infection combined with neonatal lupus erythematosus: a case reported. | Front Pediatr | 2025 | https://conductscience.org/library/papers/40574945 | PubMed |
| 40573903 | Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40573903 | PubMed |
| 40463368 | Reverse vaccinology-based design of multivalent multiepitope mRNA vaccines targeting key viral proteins of Herpes Simplex Virus type-2. | Front Immunol | 2025 | https://conductscience.org/library/papers/40463368 | PubMed |
| 40207227 | Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes. | Front Immunol | 2025 | https://conductscience.org/library/papers/40207227 | PubMed |
| 40007004 | Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy. | Viruses | 2025 | https://conductscience.org/library/papers/40007004 | PubMed |
| 39338520 | Immunological Considerations for the Development of an Effective Herpes Vaccine. | Microorganisms | 2024 | https://conductscience.org/library/papers/39338520 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39003018
GET https://conductscience.org/api/papers/v1/39003018/authors